ORA-12541: TNS : pas de processus d'écoute

	Organisme : Société de recherche sur le cancer
	Projets financés à l'Université Laval
		Assessment of a novel TLR7/8 agonist in lung cancer
		Circulating basophils and eosinophils as novel biomarkers for non-muscle invasive cancer bladder cancer
		Determinants of durable immunotherapy response in non-small cell lung cancer
		Elucidating how ASCC3 controls the chemotherapy response in colorectal cancer
		Enhancing CAR T cell functionality and controllability through state-of-the-art genome editing
		Exploiting lipid droplet biogenesis to improve the anti-cancer potential of mTOR inhibitors.
		Identifying and validating a novel metabolic vulnerability for the treatment of medulloblastoma
		Impact of vaping on lung cancer progression and response to treatment: pre-clinical investigations
		Investigating the RAS/MAPK-BRD2-ETS1 axis in cholangiocarcinoma development and progression
		New function for DEPTOR tyrosine 289 phosphorylation in glioma metabolism
		Targeting the prostate cancer metabolic program for therapeutic purposes
		The control of mRNA stability by RNA-binding proteins in breast cancer
		Understanding the early phases of prostate carcinogenesis for prevention therapies
		ZNF768 regulation of and by the cell cycle

ORA-12541: TNS : pas de processus d'écoute